AtaiBeckley (ATAI) Return on Sales (2021 - 2026)

AtaiBeckley's quarterly Return on Sales came in at 0.31% in Q1 2026, down 14.0% year-on-year from 0.37% in Q1 2025, and down 84.66% quarter-over-quarter from 0.17% in Q1 2025.

AtaiBeckley's Return on Sales history runs 5 years deep, the most recent figure standing at 0.82% for Q3 2025.

  • In Q3 2025, Return on Sales rose 576.0% year-over-year to 0.82%; the TTM figure through Sep 2025 stood at 0.51% (up 329.0% YoY), while the FY2024 annual figure was 4.83%, down 361.0% from the prior year.
  • Return on Sales for Q1 2026 stood at 0.31%, down from 0.17% in the prior quarter.
  • The five-year high for Return on Sales was 0.17% in Q1 2025, with the low at 0.31% in Q1 2026.
  • A 5-year average of 4.93% and a median of 1.85% in 2023 frame the typical range for Return on Sales.
  • Across the five-year window, Return on Sales jumped 1887 bps in 2023 and slumped 2350 bps in 2024, its largest moves.
  • AtaiBeckley's Return on Sales stood at 2.27% in 2021, then slumped by 426 bps to 11.93% in 2022, then grew by 22 bps to 9.29% in 2023, then slumped by 253 bps to 32.78% in 2024, then soared by 98 bps to 0.82% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods registered 0.82%, 0.39%, and 0.17% for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 0.00%
7 Evaxion A 64.16 Bn 64.14 Bn - 0.00%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 0.00%
10 AtaiBeckley 1.62 Bn 1.62 Bn - -0.31%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.31%
Sep 30, 2025 -0.82%
Jun 30, 2025 -0.39%
Mar 31, 2025 -0.17%
Mar 31, 2025 -0.17%
Dec 31, 2024 -32.78%
Sep 30, 2024 -6.57%
Jun 30, 2024 -2.09%
Mar 31, 2024 -1.11%
Dec 31, 2023 -9.29%
Sep 30, 2023 5.01%
Jun 30, 2023 -1.85%
Mar 31, 2023 -9.02%
Dec 31, 2022 -11.93%
Sep 30, 2022 -13.86%
Jun 30, 2022 -1.82%
Mar 31, 2022 -3.60%
Dec 31, 2021 -2.27%
Sep 30, 2021 -1.01%
Jun 30, 2021 -0.09%
Mar 31, 2021 0.00%